Fixing one piece of the healthcare puzzle is encouraging - but is it transformational? Here are 10 things we can consider to make things better.

This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

This first installment will lay the foundation for understanding how CAR T works. Future installments will focus on CAR T applications and recent innovations which further the field.

The drip, drip, drip of innovation might just be a myth. Change commonly occurs as a punctuated reality that’s a function of converging events...